BETA
BETA
Eli Lilly & Co
LLY74
$804.62arrow_drop_down2.01%-$16.57
High Growth
S&P500
LLY74
$804.62
arrow_drop_down2.01%| Key Stats | |
|---|---|
| Open | $810.30 |
| Prev. Close | $821.19 |
| EPS | 6.79 |
| Next Earnings Date | Dec 11, 2024 |
| LOW | HIGH | |
|---|---|---|
| Day Range | 803.56 | 821.98 |
| 52 Week Range | 446.56 | 966.09 |
| Ratios | |
|---|---|
| EPS | 6.79 |
| Fundamentals | |
|---|---|
| Industry average yield | 2.88% |
| Last Dividend pay date | Sep 10, 2024 |
Stock Analysis
Technicals
Summarizing what the indicators are suggesting.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Analyst rating
An aggregate view of professional's ratings.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Stock Performance
LLYarrow_drop_up2.37%
US Healthcare Sectorarrow_drop_up0.48%
US Marketarrow_drop_down0.01%
check_circle
LLY / Market
LLY exceeded the US Market which returned -0.01% over the last twenty four hours.check_circle
LLY / Healthcare Sector
LLY exceeded the US Healthcare sector which returned 0.48% over the last twenty four hours.Eli Lilly & Co (LLY) Statistics
Keep an eye on Eli Lilly & Co
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
How has Eli Lilly & Co (LLY) stock's performance compared to its sector and the market over the past year?
Over the past year, Eli Lilly & Co (LLY) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 25.05%, Eli Lilly & Co has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 51.99%, it has fallen short of the market average. This comparison highlights Eli Lilly & Co's performance relative to both its sector and the overall market over the last year.
help
What is the PE ratio of Eli Lilly & Co (LLY) stock?
The PE (Price to Earnings) ratio of Eli Lilly & Co (LLY) is currently 118.5. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help
What is the EPS of Eli Lilly & Co (LLY) stock?
The Earnings Per Share (EPS) for Eli Lilly & Co (LLY), calculated on a diluted basis, is $6.79. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help
What is the operating margin of Eli Lilly & Co (LLY) stock?
The operating margin for Eli Lilly & Co (LLY) is 31.2%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help
What is the EBITDA of Eli Lilly & Co (LLY) stock?
The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Eli Lilly & Co (LLY) is $13.55B. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help
How much debt does Eli Lilly & Co (LLY) have?
Eli Lilly & Co (LLY) has a total debt of $26.35B. The net debt, which accounts for cash and cash equivalents against the total debt, is $23.75B.
Sign up for our newsletter
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.